البلد: أستراليا
اللغة: الإنجليزية
المصدر: Department of Health (Therapeutic Goods Administration)
Moxifloxacin
Bayer Australia Ltd
Medicine Registered
AVELOX ® IV CMI 1 AVELOX ® IV (AV·E·LOX) _moxifloxacin hydrochloride_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Avelox IV. It does not contain all of the available information on Avelox IV. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you receiving Avelox IV against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT RECEIVING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET IN A SAFE PLACE, EVEN AFTER YOUR TREATMENT IS FINISHED. You may need to read it again. WHAT AVELOX IV IS USED FOR Avelox IV is a sterile intravenous antibiotic used in adults for the treatment of serious infections of the lungs and airways. It can also be used to treat severe, complicated skin and skin structure infections. Avelox IV is used to start the treatment and then your doctor may prescribe tablets to complete the course. Remember to read the Consumer Medicine Information for Avelox tablets, if you receive them, because it may contain additional information specific to the tablets. Avelox IV contains the active ingredient, moxifloxacin, which is an antibiotic belonging to a group of medicines called quinolones. These antibiotics work by killing the bacteria that are causing your infection. Avelox IV will not work against infections caused by viruses such as colds or اقرأ الوثيقة كاملة